CAS: 1300031-49-5 - I-BET151
Formula:C23H21N5O3
InChI:InChI=1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1
InChI key:InChIKey=VUVUVNZRUGEAHB-CYBMUJFWSA-N
SMILES:O=C1NC2=CN=C3C=C(C(OC)=CC3=C2N1C(C4=NC=CC=C4)C)C=5C(=NOC5C)C
2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-
CAS:1300031-49-5
Formula:
C23H21N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
415.4445
Ref: IN-DA000TW9
1mg | 61.00 € | ||
5mg | 126.00 € | ||
10mg | 200.00 € | ||
50mg | 569.00 € | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
I-BET151
CAS:1300031-49-5
I-BET151 (GSK1210151A) (GSK1210151A) is a specific BET inhibitor for BRD2/3/4 (IC50: 0.5/0.25/0.79 μM, in cell-free …
Formula:
C23H21N5O3
Purity:
98.86% - 99.63%
Color and Shape:
Solid
Molecular weight:
415.44
Ref: TM-T2120
1mg | 48.00 € | ||
2mg | 64.00 € | ||
5mg | 99.00 € | ||
10mg | 118.00 € | ||
25mg | 203.00 € | ||
50mg | 337.00 € | ||
100mg | 503.00 € | ||
500mg | 1,105.00 € | ||
1mL*10mM (DMSO) | 105.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 10-F861699
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
I-BET 151
Controlled ProductCAS:1300031-49-5
Applications I-BET 151 is part of a novel series of quinoline isoxazole BET family bromodomain …
Formula:
C23H21N5O3
Color and Shape:
Neat
Molecular weight:
415.44
Ref: TR-I120050
5mg | 147.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
I-BET 151
CAS:1300031-49-5
Isoxazole class pan-BET family inhibitor
Formula:
C23H21N5O3
Purity:
Min. 95%
Molecular weight:
415.44 g/mol
Ref: 3D-FD43075
2mg | 338.00 € | ||
5mg | 355.00 € | ||
10mg | 506.00 € | ||
25mg | 839.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025